BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37738537)

  • 1. HIV and Early Treatment Outcomes Among Women With Cervical Cancer Treated With Concurrent Chemoradiation in Tanzania.
    Mrema AS; Ngoma M; Josiah C; Lugina E; Mvungi N; Paul M; Mkuchika E; Nundu E; Iddy SK; Rugengamanzi E; Vuhahula YM; Kiwanga FC; Wood C; Mwaiselage J
    JCO Glob Oncol; 2023 Sep; 9():e2200441. PubMed ID: 37738537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up on HIV infected and non-infected women with cervical cancer from Tanzania: staging, access to cancer-directed therapies and associated survival in a real-life remote setting.
    Glasmeyer L; Mcharo RD; Torres L; Lennemann T; Danstan E; Mwinuka N; Judick M; Mueller W; Mbuya W; Hölscher M; Lellé R; Geldmacher C; Kroidl A; France JR
    BMC Cancer; 2022 Aug; 22(1):892. PubMed ID: 35971100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and geographic distribution of HIV-positive women diagnosed with cervical cancer in Dar es Salaam, Tanzania.
    Lovgren K; Soliman AS; Ngoma T; Kahesa C; Meza J
    Int J STD AIDS; 2016 Oct; 27(12):1049-1056. PubMed ID: 26464500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Completion of and early response to chemoradiation among human immunodeficiency virus (HIV)-positive and HIV-negative patients with locally advanced cervical carcinoma in South Africa.
    Simonds HM; Wright JD; du Toit N; Neugut AI; Jacobson JS
    Cancer; 2012 Jun; 118(11):2971-9. PubMed ID: 22072021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.
    ter Meulen J; Eberhardt HC; Luande J; Mgaya HN; Chang-Claude J; Mtiro H; Mhina M; Kashaija P; Ockert S; Yu X
    Int J Cancer; 1992 Jun; 51(4):515-21. PubMed ID: 1318265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics.
    Di Salvo I; Mnzava D; Nicoletti GJ; Senkoro E; Ndege RC; Huang DJ; Makunja NT; Kassiga GI; Kaufmann AM; Weisser M; Kind AB
    BMC Health Serv Res; 2023 Mar; 23(1):234. PubMed ID: 36894985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between CD4 Count and Chemoradiation Therapy Outcomes Among Cervical Cancer Patients With HIV.
    Grover S; Mehta P; Wang Q; Bhatia R; Bvochora-Nsingo M; Davey S; Iyengar M; Shah S; Shin SS; Zetola NM
    J Acquir Immune Defic Syndr; 2020 Oct; 85(2):201-208. PubMed ID: 32568769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Cervical Cancer Screening Programs in Côte d'Ivoire, Guyana, and Tanzania: Effect of HIV Status.
    Anderson J; Wysong M; Estep D; Besana G; Kibwana S; Varallo J; Sun K; Lu E
    PLoS One; 2015; 10(9):e0139242. PubMed ID: 26405784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control.
    Hall MT; Smith MA; Simms KT; Barnabas R; Murray JM; Canfell K
    Int J Cancer; 2021 Jul; 149(2):297-306. PubMed ID: 33634857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agreement between careHPV and hybrid capture 2 in detecting high-risk HPV in women in Tanzania.
    Katanga J; Kjaer SK; Manongi R; Pembe AB; Iftner T; Waldstrom M; Mwaiselage J; Rasch V
    Acta Obstet Gynecol Scand; 2021 Apr; 100(4):786-793. PubMed ID: 33497480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the pattern of Kaposi's sarcoma at Ocean Road Cancer Institute in Tanzania (2006-2011).
    Koski L; Ngoma T; Mwaiselage J; Le L; Soliman AS
    Int J STD AIDS; 2015 Jun; 26(7):470-8. PubMed ID: 25080290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vertical HIV transmission within 18 months post partum among women on lifelong antiretroviral therapy for HIV in Dar es Salaam, Tanzania: a prospective cohort study.
    Lyatuu GW; Urrio R; Naburi H; Lyaruu P; Simba B; Siril H; Philipo E; Machumi L; Kibao A; Kajoka D; Nyamhagatta M; Sando D; Biberfeld G; Orsini N; Kilewo C; Ekström AM
    Lancet HIV; 2023 Jan; 10(1):e33-e41. PubMed ID: 36495896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between invasive cancer of the cervix and HIV-1 infection in Tanzania: the need for dual screening.
    Kahesa C; Mwaiselage J; Wabinga HR; Ngoma T; Kalyango JN; Karamagi CA
    BMC Public Health; 2008 Jul; 8():262. PubMed ID: 18664298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival in Cervical Cancer and Its Predictors at Ocean Road Cancer Institute From January to December 2012.
    Khamis SI; Mrema AS; Katanga J; Lugina EL
    JCO Glob Oncol; 2021 May; 7():734-739. PubMed ID: 34010012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus.
    Grover S; Ning MS; Bale M; Lichter KE; Shah S; Bvochora-Nsingo M; Chiyapo S; Balang D; McGinnis GJ; Ralefala T; Moloi T; Luckett R; Ramogola-Masire D; Robertson ES; Zetola NM
    Int J Gynecol Cancer; 2021 Sep; 31(9):1220-1227. PubMed ID: 34312220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics and Prognosis of Cervical Cancer Patients with Human Immunodeficiency Virus Infection: A Retrospective Study.
    Wang R; Zhang Y; Zhu Y; Li Q
    Gynecol Obstet Invest; 2022; 87(5):324-332. PubMed ID: 36037794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal function impairment in cervical cancer patients treated with cisplatin-based chemoradiation: A review of medical records in a Zimbabwean outpatient department.
    Manyau PMC; Mabeka M; Mudzviti T; Kadzatsa W; Nyamhunga A
    PLoS One; 2021; 16(2):e0245383. PubMed ID: 33626044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
    Testa AC; Ferrandina G; Moro F; Pasciuto T; Moruzzi MC; De Blasis I; Mascilini F; Foti E; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta MA; Valentini AL; Rufini V; Scambia G
    Ultrasound Obstet Gynecol; 2018 May; 51(5):684-695. PubMed ID: 28620930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of in-house pathology services on downstaging cervical cancer in Tanzania over an 18-year period.
    Fuss CG; Msami K; Kahesa C; Mwaiselage J; Gordon A; Sohler N; Mattick LJ; Soliman AS
    Cancer Causes Control; 2024 Jan; 35(1):93-101. PubMed ID: 37574489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV serostatus and tumor differentiation among patients with cervical cancer at Bugando Medical Centre.
    Matovelo D; Magoma M; Rambau P; Massinde A; Masalu N
    BMC Res Notes; 2012 Aug; 5():406. PubMed ID: 22862747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.